14 Mar 2019

STAINING MAY OCCUR AFTER SCLEROTHERAPY

    By Ronald F. Bush, MD, FACS and Peggy Bush, APRN Staining (hemosiderin deposition) after sclerotherapy is not infrequent. Staining results from trapped blood that occurs after sclerotherapy injections or red cell extravasation. All vessels will clot to some degree unless methods are taken to minimize clotting at the

0
14 Mar 2019

PCF OR ‘FOAM IN A CAN.’ READ THE STUDY AND YOU DECIDE

Roger Hogue, MD, has conducted a new study that makes the case that PCF foam structure and visual foam quality is as good or better than proprietary “Foam in a Can.” Whether you prefer to buy the foam you use or whether you prefer to compound it, this detailed study

0
06 Mar 2019

A ‘FOUNTAIN OF YOUTH’ PILL? ‘Sure, if you are a mouse!’

      By Marisa Taylor Renowned Harvard University geneticist David Sinclair recently made a startling assertion: Scientific data shows he has knocked more than two decades off his biological age. What’s the 49-year-old’s secret? He says his daily regimen includes ingesting a molecule his own research found improved the

0
14 Feb 2019

ENCOURAGE AGING PATIENTS TO DEVELOP A LATE LIFE PLAN

  By Judith Graham About 25 million Americans who are aging in place rely on help from other people and devices such as canes, raised toilets or shower seats to perform essential daily activities, according to a new study documenting how older adults adapt to their changing physical abilities. But a substantial

0
14 Jan 2019

GET OUT OF THE WAY OPIOIDS, METH IS MAKING A BIG, DEADLY COMEBACK

By Carmen Heredia Rodriguez In 2016, news reports warned the public of an opioid epidemic gripping the nation. But Madeline Vaughn, then a lead clinical intake coordinator at the Houston-based addiction treatment organization Council on Recovery, sensed something different was going on with the patients she checked in from the

0
07 Jan 2019

MDLINX SURVEY: MAJORITY HAVE LOST FAITH IN VALUE OF THE MOC

A survey of 515 U.S. physicians by MDLinx revealed that 65 percent want to see the 10-year maintenance of certification (MOC) process ended because it adds no clinical value to the practice of medicine. The recent survey, reported in FierceHealthcare, found that almost 55 percent of respondents want to see those controversial MOC requirements

0
07 Jan 2019

MEDTRONIC GETS OK TO STUDY PATIENTS WITH BICUSPID AORTIC VALUES USING COREVALVE EVOLUT TAVR SYSTEM

The U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) for Medtronic to initiate a single-arm study to evaluate the CoreValve Evolut TAVR system in patients with bicuspid aortic valves who are at low risk of surgical mortality. Medtronic separately received FDA approval for revised commercial

0
05 Jan 2019

WHEN MEDICINE MAKES PATIENTS SICKER

  By Sydney Lupkin Photos by Heidi de Marco Despite the jackhammer-like rhythm of a mechanical ventilator, Alicia Moreno had dozed off in a chair by her 1-year-old’s hospital bed, when a doctor woke her with some bad news: The common stool softener her son, Anderson, was given months earlier had been

0
05 Jan 2019

IT’S A LITTLE-KNOWN SECRET THAT PATIENTS CAN GET THOUSANDS OF DOLLARS DIRECTLY FROM A DRUGMAKER

      By Sarah Jane Tribble   Kip Burgess was relieved last year when pharmaceutical giant Amgen overnighted him a $2,976 check to help pay for his go-to arthritis drug, Enbrel. The 36-year-old psychologist had run into an increasingly common problem: The copay coupon sent by Thousand Oaks, Calif.-based Amgen

0
03 Jan 2019

IN.PACT ADMIRAL:  MEDTRONIC SHARES FIVE-YEAR DRUG-COATED BALLOON DATA

  Medtronic plc data presented Nov. 12 reinforce the durability, safety, and effectiveness of the IN.PACT Admiral drug-coated balloon (DCB) in patients with peripheral artery disease in the superficial femoral and popliteal arteries. The five-year and final results from the pivotal IN.PACT SFA Trial and one-year all-subjects results from the

0